| Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
| 02/02/2018 | 18:30 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:DSCI | Derma Sciences, Inc. |
| 21/03/2017 | 11:02 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:DSCI | Derma Sciences, Inc. |
| 15/03/2017 | 19:26 | Edgar (US Regulatory) | Confidential Treatment Order (ct Order) | NASDAQ:DSCI | Derma Sciences, Inc. |
| 07/03/2017 | 22:04 | Edgar (US Regulatory) | Termination of Registration of a Class of Security Under Section 12(b) (15-12b) | NASDAQ:DSCI | Derma Sciences, Inc. |
| 07/03/2017 | 12:05 | Edgar (US Regulatory) | Amended Current Report Filing (8-k/a) | NASDAQ:DSCI | Derma Sciences, Inc. |
| 28/02/2017 | 18:35 | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (sc 13d/a) | NASDAQ:DSCI | Derma Sciences, Inc. |
| 24/02/2017 | 23:39 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:DSCI | Derma Sciences, Inc. |
| 24/02/2017 | 15:27 | Edgar (US Regulatory) | (25-NSE) | NASDAQ:DSCI | Derma Sciences, Inc. |
| 24/02/2017 | 15:03 | Edgar (US Regulatory) | Post-effective Amendment to Registration Statement (pos Am) | NASDAQ:DSCI | Derma Sciences, Inc. |
| 24/02/2017 | 14:45 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:DSCI | Derma Sciences, Inc. |
| 24/02/2017 | 14:31 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:DSCI | Derma Sciences, Inc. |
| 23/02/2017 | 14:45 | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NASDAQ:DSCI | Derma Sciences, Inc. |
| 23/02/2017 | 14:39 | Edgar (US Regulatory) | Amended Tender Offer Statement by Third Party (sc To-t/a) | NASDAQ:DSCI | Derma Sciences, Inc. |
| 23/02/2017 | 14:30 | GlobeNewswire Inc. | Integra LifeSciences Announces Acceptance of Shares Tendered into Offer for Derma Sciences, Inc. | NASDAQ:DSCI | Derma Sciences, Inc. |
| 25/01/2017 | 22:42 | Edgar (US Regulatory) | Statement of Ownership: Solicitation (sc 14d9) | NASDAQ:DSCI | Derma Sciences, Inc. |
| 25/01/2017 | 22:18 | Edgar (US Regulatory) | Tender Offer Statement by Third Party (sc To-t) | NASDAQ:DSCI | Derma Sciences, Inc. |
| 25/01/2017 | 14:30 | GlobeNewswire Inc. | Integra LifeSciences Commences Previously Announced Cash Tender Offer to Acquire Derma Sciences, Inc. | NASDAQ:DSCI | Derma Sciences, Inc. |
| 23/01/2017 | 17:10 | Edgar (US Regulatory) | Statement of Beneficial Ownership (sc 13d) | NASDAQ:DSCI | Derma Sciences, Inc. |
| 17/01/2017 | 23:26 | PR Newswire (US) | Harwood Feffer LLP Announces Investigation of Derma Sciences Inc. | NASDAQ:DSCI | Derma Sciences, Inc. |
| 17/01/2017 | 22:42 | Edgar (US Regulatory) | Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c) | NASDAQ:DSCI | Derma Sciences, Inc. |
| 12/01/2017 | 12:03 | Edgar (US Regulatory) | Written Communication Relating to an Issuer or Third Party (sc To-c) | NASDAQ:DSCI | Derma Sciences, Inc. |
| 11/01/2017 | 22:15 | Business Wire | Derma Sciences Buys MEDIHONEY® Brand From Long-Term Partner | NASDAQ:DSCI | Derma Sciences, Inc. |
| 11/01/2017 | 17:05 | Business Wire | DERMA SCIENCES, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout | NASDAQ:DSCI | Derma Sciences, Inc. |
| 11/01/2017 | 15:33 | PR Newswire (US) | DERMA (DSCI) ALERT: Johnson & Weaver, LLP Launches an Investigation into the Fairness of Price and Process in Proposed Sale o... | NASDAQ:DSCI | Derma Sciences, Inc. |
| 11/01/2017 | 02:00 | Business Wire | Derma Sciences to Be Acquired by Integra LifeSciences for $7.00 Per Share of Common Stock in Cash | NASDAQ:DSCI | Derma Sciences, Inc. |
| 11/01/2017 | 02:00 | GlobeNewswire Inc. | Integra LifeSciences to Acquire Derma Sciences Inc. and Announces Preliminary Fourth Quarter and Full Year 2016 Financial Res... | NASDAQ:DSCI | Derma Sciences, Inc. |
| 09/01/2017 | 12:00 | GlobeNewswire Inc. | Immunomedics Announces Reconstituted Board of Directors and Leadership Succession Plan | NASDAQ:DSCI | Derma Sciences, Inc. |
| 10/11/2016 | 22:00 | Business Wire | Derma Sciences to Present at the Canaccord Genuity Medical Technologies & Diagnostics Forum | NASDAQ:DSCI | Derma Sciences, Inc. |
| 10/11/2016 | 13:30 | Business Wire | Derma Sciences Reports 2016 Third Quarter Financial Results | NASDAQ:DSCI | Derma Sciences, Inc. |
| 09/11/2016 | 23:24 | Edgar (US Regulatory) | Quarterly Report (10-q) | NASDAQ:DSCI | Derma Sciences, Inc. |